Abstract:IntroductionThymic carcinoma is a rare, invasive mediastinal neoplasm with a tendency to metastasize. They constitute a heterogeneous group of tumors that present differently in terms of both behavior and prognosis.Case reportWe present a case of thymic carcinoma in a 55-year-old male patient known to suffer from Myasthenia gravis, whose chief complaints were fatigability, ptosis and coughing. All electromyography studies were done along with excision biopsy to reach the definitive diagnosis.Results and conclu… Show more
“…There are limited data about the incidence of the small intestinal metastasis in patients with thymic carcinoma and the mechanism of distant metastasis from thymic carcinoma to small intestine remains unclear. Previous study suggested that extrathoracic metastases may occur because the tumor cells penetrated and spread from the great vessels in thymic carcinoma [ 2 ]. In our case, we indicated that hematogenous metastasis is the primary pathway leading to the metastasis of thymic carcinoma to the small intestine.…”
Section: Discussionmentioning
confidence: 99%
“…Thymic carcinoma is a rare mediastinal neoplasm and has been reported to comprise only 0.06% of all thymic neoplasms [ 1 ]. Thymic carcinoma has a high malignant potential with a tendency to distant metastasis [ 2 ]. 80% of cases have local invasion of contiguous mediastinal structures, and 40% of cases present metastatic spread to bones, lung, pleura, liver, or lymph node [ 3 ].…”
Background
Thymic carcinoma is a rare mediastinal neoplasm with a high malignant potential. It often shows pleural invasion and distant metastasis. The metastasis of thymic carcinoma to the small intestine is rarely reported and difficult to distinguish from other gastrointestinal tract tumors.
Case presentation
An elderly man presented with lower abdominal pain for 2 months. Abdominal CT showed a mass communicated with the small intestinal lumen. After radical resection of the small intestinal tumor, resected specimens showed moderately differentiated squamous-cell carcinoma with lymph nodes metastases. The patient received chest CT and was found to have a mass in anterior mediastinum. Biopsies of the mass revealed thymic squamous-cell carcinoma.
Conclusions
We highlighted the metastasis of thymic carcinoma to the small intestine is rare and easily misdiagnosed. In patients with a mass communicated with the small intestinal lumen, a suspicion of thymic carcinoma metastasis should not be overlooked and we should make accurate differential diagnosis from the other small intestinal tumors.
“…There are limited data about the incidence of the small intestinal metastasis in patients with thymic carcinoma and the mechanism of distant metastasis from thymic carcinoma to small intestine remains unclear. Previous study suggested that extrathoracic metastases may occur because the tumor cells penetrated and spread from the great vessels in thymic carcinoma [ 2 ]. In our case, we indicated that hematogenous metastasis is the primary pathway leading to the metastasis of thymic carcinoma to the small intestine.…”
Section: Discussionmentioning
confidence: 99%
“…Thymic carcinoma is a rare mediastinal neoplasm and has been reported to comprise only 0.06% of all thymic neoplasms [ 1 ]. Thymic carcinoma has a high malignant potential with a tendency to distant metastasis [ 2 ]. 80% of cases have local invasion of contiguous mediastinal structures, and 40% of cases present metastatic spread to bones, lung, pleura, liver, or lymph node [ 3 ].…”
Background
Thymic carcinoma is a rare mediastinal neoplasm with a high malignant potential. It often shows pleural invasion and distant metastasis. The metastasis of thymic carcinoma to the small intestine is rarely reported and difficult to distinguish from other gastrointestinal tract tumors.
Case presentation
An elderly man presented with lower abdominal pain for 2 months. Abdominal CT showed a mass communicated with the small intestinal lumen. After radical resection of the small intestinal tumor, resected specimens showed moderately differentiated squamous-cell carcinoma with lymph nodes metastases. The patient received chest CT and was found to have a mass in anterior mediastinum. Biopsies of the mass revealed thymic squamous-cell carcinoma.
Conclusions
We highlighted the metastasis of thymic carcinoma to the small intestine is rare and easily misdiagnosed. In patients with a mass communicated with the small intestinal lumen, a suspicion of thymic carcinoma metastasis should not be overlooked and we should make accurate differential diagnosis from the other small intestinal tumors.
“…Rare, they nevertheless represent 20% of all mediastinal tumors and 50% of those located in the anterior mediastinum, with very few extrathoracic spread [1]. Thymic carcinoma is more aggressive than thymoma, and accounts for about 15% of the incidence of thymic tumors [2]. The most common histological types of thymic carcinoma are squamous cell carcinoma, lymphoepithelial carcinoma, undifferentiated carcinoma and so on.…”
Epithelial neoplasms of the thymus is a relatively rare malignancy. In this report, we present a case of thymic carcinoma of a 68-yearold man with hepatic metastasis, which with the severe hypokalemia, hypoproteinemia, and fatigue of concomitant symptom. After positive symptomatic treatment such as correction of electrolyte disorder, supplementation of albumin and nutritional support, the patient’s general condition recovered and improved. Then, we reviewed the literature on the treatment of thymic carcinoma, and decided to use immunotherapy combined with chemotherapy to treat this case of advanced thymic squamous carcinoma, expecting to have a good efficacy and improve the progression-free and overall survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.